1. RhoA-ROCK2 signaling possesses complex pathophysiological functions in cancer progression and shows promising therapeutic potential
   Yidi Ning et al, 2024, Cancer Cell International CrossRef
2. Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex
   Yayun Jiang et al, 2017, Oncology Reports CrossRef
3. RhoC (RHOC)
   Francisco M. Vega et al, 2016, Encyclopedia of Signaling Molecules CrossRef
4. RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target
   Pavana Thomas et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
5. Effect of RhoC on the epithelial-mesenchymal transition process induced by TGF-β1 in lung adenocarcinoma cells
   Xiaoxiao Lu et al, 2016, Oncology Reports CrossRef
6. Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare
   Pavol Zubor et al, 2020, Cancers CrossRef
7. EMT induces characteristic changes of Rho GTPases and downstream effectors with a mitosis-specific twist
   Kamran Hosseini et al, 2023, Physical Biology CrossRef
8. Discriminating high-risk cervical Human Papilloma Virus infections with urinary biomarkers via non-targeted GC-MS-based metabolomics
   Filipa Godoy-Vitorino et al, 2018, PLOS ONE CrossRef
9. Retracted: Silencing ARHGAP9 correlates with the risk of breast cancer and inhibits the proliferation, migration, and invasion of breast cancer
   Tianyi Wang et al, 2018, Journal of Cellular Biochemistry CrossRef
10. Cancer Stem Cells and Radioresistance: Rho/ROCK Pathway Plea Attention
    Annapurna Pranatharthi et al, 2016, Stem Cells International CrossRef
11. RhoC (RHOC)
    Francisco M. Vega et al, 2018, Encyclopedia of Signaling Molecules CrossRef
12. The Role of Cytokines in Epithelial–Mesenchymal Transition in Gynaecological Cancers: A Systematic Review
    Irene Ray et al, 2023, Cells CrossRef